Fintel on MSN3d
LifeSci Capital Initiates Coverage of Monte Rosa Therapeutics (GLUE) with Outperform Recommendation
Fintel reports that on March 12, 2025, LifeSci Capital initiated coverage of Monte Rosa Therapeutics (NasdaqGS:GLUE) with a ...
Monte Rosa Therapeutics initiated with an Outperform at LifeSci Capital
LifeSci Capital initiated coverage of Monte Rosa Therapeutics (GLUE) with an Outperform rating and $19 price target Optimize Your Investment ...
pharmaphorum5d
Novartis pays $150m upfront for Monte Rosa degrader drug
The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...
Sportskeeda5d
Montez Ford pens down heartfelt message ahead of major WWE championship match
WWE Superstar Montez Ford shared a heartfelt message on social media heading into a major title match. The Street Profits are set to challenge #DIY for the Tag Team Championship this Friday on ...
Yahoo Finance2d
Monte Rosa Therapeutics, Inc. (GLUE)
After hours: March 12 at 5:22:49 PM EDT Loading Chart for GLUE ...
The New York Times2d
Movie Reviews
The director Catherine Gund fuses work from multiple artists with archival footage and interviews to craft an exploration of Black resilience. By Alissa Wilkinson In this coming-of-age drama from ...
yr.no1d
Monte Rosa
It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...